A premier regional contract-research organization (CRO) for clinical outsourcing to Russia, Ukraine, Belarus, Georgia, Eastern Europe and Israel.
Cromos Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical outsourcing to Russia, Ukraine, Belarus, Georgia, countries of Eastern Europe and Israel – areas with very compelling environment for biopharmaceutical research. The company manages Phase I-IV clinical trials, bioequivalence and observational studies and has been successfully operating since 2004.
Our business model is a product of the most validated Western solutions which are carefully tailored to local environments.
Full compliance with ICH GCP regulations, motivated and experienced investigators with impeccable reputations, large patient population is the integral to our ability to provide high quality and affordable services.
As project managers, our "cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos Pharma you get an invariable guarantee that your project will be handled by the "A-team".
In 2012 Cromos Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead.
Cromos Pharma offers budget-friendly clinical outsourcing solutions via innovative operational structure and project-specific alliances. We guarantee speed, quality, and best experts in the field. Our intricate knowledge of the market, long-term working relationship and personal ties with the best research centers and health care authorities translate into a unique capability to accomplish the most difficult tasks.
Please, contact us to learn more about Cromos Pharma clinical trial services.
Cromos Pharma has successfully completed the inspection by RosZdravNadzor, the Russian state regulatory agency. / 06.02.2014
Cromos Pharma at Scope Summit 2014 in Miami (FL), USA on 4-6 February 2014. / 21.01.2014
Clinical trials in Israel / 16.01.2014
Cromos Pharma's CEO, Dr Vlad Bogin will attend JPMorgan Healthcare Conference in San Francisco, USA on 13-16 January 2014. / 25.12.2013